1. Renin angiotensin system and its role in biomarkers and treatment in gliomas

   • Alexander Perdomo-Pantoja
   • Sonia Iliana Mejía-Pérez
   • Talia Wegman-Ostrosky

   Topic Review 16 February 2018 Pages: 1 - 15

   

2. Therapeutic efficacy of a synthetic epsin mimetic peptide in glioma tumor model: uncovering multiple mechanisms beyond the VEGF-associated tumor angiogenesis

   • Jerry Dong
   • Debra Saunders
   • Hong Chen

   Laboratory Investigation 22 January 2018 Pages: 17 - 27

   

3. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin

   • Prit Benny Malgulwar
   • Aruna Nambirajan
   • Mehar Chand Sharma

   Laboratory Investigation 22 January 2018 Pages: 29 - 39

   

4. Genomic analysis of synchronous intracranial meningiomas with different histological grades

   • Tamrin Chowdhury
   • Yongjin Yoo
   • Ji Yeoun Lee

   Laboratory Investigation 08 February 2018 Pages: 41 - 48

   

5. High expression of cystine–glutamate antiporter xCT (SLC7A11) is an independent biomarker for epileptic seizures at diagnosis in glioma

   • Mai Froberg Sørensen
   • Sólborg Berglind Heimisdóttir
   • Christoph Patrick Beier

   Laboratory Investigation 05 February 2018 Pages: 49 - 53

   

6. Long-term endocrine effects and trends in body mass index changes in patients with childhood-onset brain tumors

   • Go Hun Seo
   • Jin-Ho Choi
   • Han-Wook Yoo

   Clinical Study 19 January 2018 Pages: 55 - 62

   

7. Prediction of progression in skull base meningiomas: additional benefits of apparent diffusion coefficient value

   • Ching-Chung Ko
   • Sher-Wei Lim
   • Yow-Ling Shiue

   Clinical Study 20 January 2018 Pages: 63 - 71

   

8. Efficacy, safety and outcome of frameless image-guided robotic radiosurgery for brain metastases after whole brain radiotherapy

   • Laura-Nanna Lohkamp
   • Peter Vajkoczy
   • Markus Kufeld

   Clinical Study 29 January 2018 Pages: 73 - 81

   

9. Pediatric neuro-oncology survival disparities in California

   • Tabitha Cooney
   • Paul G. Fisher
   • Sonia Partap

   Clinical Study 07 February 2018 Pages: 83 - 97

   

10. The predictive potential of hyponatremia for glioblastoma patient survival

    • Oliver D. Mrowczynski
    • Alexandre J. Bourcier
    • Elias B. Rizk

    Clinical Study 25 January 2018 Pages: 99 - 104

    

11. Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma

    • Jiayi Huang
    • Jian L. Campian
    • Albert H. Kim

    Clinical Study 27 January 2018 Pages: 105 - 111

    

12. The diagnostic value of preoperative inflammatory markers in craniopharyngioma: a multicenter cohort study

    • Ming Chen
    • Shi-hao Zheng
    • Shi-ting Li

    Clinical Study 31 January 2018 Pages: 113 - 122

    

13. Surgical treatment of glioblastoma in the elderly: the impact of complications

    • Michael Karsy
    • Nam Yoon
    • Sarah T. Menacho

    Clinical Study 01 February 2018 Pages: 123 - 132

    

14. Clinical applicability of and changes in perfusion MR imaging in brain metastases after stereotactic radiotherapy

    • M. Kerkhof
    • I. Ganeff
    • M. J. Vos

    Clinical Study Open access 01 February 2018 Pages: 133 - 139

    

15. Rechallenge with bevacizumab in patients with glioblastoma progressing off therapy

    • Charlotte Bronnimann
    • Cristina Izquierdo
    • François Ducray

    Clinical Study 31 January 2018 Pages: 141 - 145

    

16. End-of-life care of children with diffuse intrinsic pontine glioma

    • Fyeza Hasan
    • Kevin Weingarten
    • Ute Bartels

    Clinical Study 03 February 2018 Pages: 147 - 153

    

17. Standard dose and dose-escalated radiation therapy are associated with favorable survival in select elderly patients with newly diagnosed glioblastoma

    • William C. Jackson
    • Christina I. Tsien
    • Michelle M. Kim

    Clinical Study 01 February 2018 Pages: 155 - 162

    

18. Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?

    • Caroline Happold
    • Thierry Gorlia
    • For the EORTC Brain Tumor Group and on behalf of the CENTRIC and CORE Clinical Trial Groups

    Clinical Study 08 February 2018 Pages: 163 - 171

    

19. Solitary-fibrous tumor/hemangiopericytoma of the central nervous system: a population-based study

    • Connor J. Kinslow
    • Samuel S. Bruce
    • Tony J. C. Wang

    Clinical Study 09 February 2018 Pages: 173 - 182

    

20. Programmed death ligand 1 expression and tumor infiltrating lymphocytes in neurofibromatosis type 1 and 2 associated tumors

    • Shiyang Wang
    • Benjamin Liechty
    • Matthias A. Karajannis

    Clinical Study 09 February 2018 Pages: 183 - 190

    

21. Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM)

    • Anna Niwińska
    • Katarzyna Pogoda
    • Agnieszka Jagiełło-Gruszfeld

    Clinical Study 12 February 2018 Pages: 191 - 198

    

22. Phase I trial of dasatinib, lenalidomide, and temozolomide in children with relapsed or refractory central nervous system tumors

    • Nathan J. Robison
    • Kee Kiat Yeo
    • Girish Dhall

    Clinical Study 09 February 2018 Pages: 199 - 207

    

23. Factors affecting early versus late remission in acromegaly following stereotactic radiosurgery

    • Mohana Rao Patibandla
    • Zhiyuan Xu
    • Jason P. Sheehan

    Clinical Study 07 February 2018 Pages: 209 - 216

    

24. Letter to the editor: local alkylating chemotherapy applied immediately after 5-ALA guided resection of glioblastoma does not provide additional benefit

    • Alexandre Roux
    • Marc Zanello
    • Johan Pallud

    Letter to the Editor 20 January 2018 Pages: 217 - 218

25. Is there a role of breast pathologist in diagnostic challenges of discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis?

    • Kadri Altundag

    Letter to the Editor 31 January 2018 Pages: 219 - 219